{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:43:50Z","timestamp":1792118630885,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellimm.2026.105164","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:46:03Z","timestamp":1791906363000},"page":"105164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rethinking CD47 an innate immune checkpoint and immunotherapeutic target in malaria pathogenesis: A narrative review"],"prefix":"10.1016","volume":"430","author":[{"given":"Aarti","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2026.105164_bb0005","unstructured":"https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2025. (n.d.)."},{"issue":"7481","key":"10.1016\/j.cellimm.2026.105164_bb0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cellimm.2026.105164_bb0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jiu491","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia","volume":"211","author":"Takala-Harrison","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.cellimm.2026.105164_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006499","article-title":"Consequences of insecticide resistance on malaria transmission","volume":"13","author":"Alout","year":"2017","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000406","article-title":"A research agenda to underpin malaria eradication","volume":"8","author":"Alonso","year":"2011","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.cellimm.2026.105164_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (Mosquirix\u2122): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"issue":"9","key":"10.1016\/j.cellimm.2026.105164_bb0035","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S1473-3099(22)00273-0","article-title":"Efficacy of RTS,S\/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5\u201317 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial","volume":"22","author":"Samuels","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.cellimm.2026.105164_bb0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40267-022-00937-3","article-title":"RTS,S\/AS01 malaria vaccine (Mosquirix\u00ae): a profile of its use","volume":"38","author":"Syed","year":"2022","journal-title":"Drugs Ther. Perspect."},{"issue":"4","key":"10.1016\/j.cellimm.2026.105164_bb0045","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biocel.2004.10.009","article-title":"Malaria: immune evasion by parasites","volume":"37","author":"Hisaeda","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.cellimm.2026.105164_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-019-0158-z","article-title":"T cell-mediated immunity to malaria","volume":"19","author":"Kurup","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.cellimm.2026.105164_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12628","article-title":"Immune effector mechanisms in malaria: an update focusing on human immunity","volume":"41","author":"Moormann","year":"2019","journal-title":"Parasite Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2026.105164_bb0060","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/IAI.01426-15","article-title":"CD47-SIRP\u03b1 interactions regulate macrophage uptake of plasmodium falciparum-infected erythrocytes and clearance of malaria in vivo","volume":"84","author":"Ayi","year":"2016","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.cellimm.2026.105164_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nri1859","article-title":"The SIRP family of receptors and immune regulation","volume":"6","author":"Barclay","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"23","key":"10.1016\/j.cellimm.2026.105164_bb0075","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1182\/blood-2011-10-386805","article-title":"CD47 functions as a molecular switch for erythrocyte phagocytosis","volume":"119","author":"Burger","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cellimm.2026.105164_bb0080","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1073\/pnas.1418144112","article-title":"CD47 regulates the phagocytic clearance and replication of the plasmodium yoelii malaria parasite","volume":"112","author":"Banerjee","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.cellimm.2026.105164_bb0085","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1907653118","article-title":"CD47 blockade reduces the pathologic features of experimental cerebral malaria and promotes survival of hosts with plasmodium infection","volume":"118","author":"Torrez Dulgeroff","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.cellimm.2026.105164_bb0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14787210.2022.2044794","article-title":"Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs","volume":"20","author":"Baindara","year":"2022","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"3","key":"10.1016\/j.cellimm.2026.105164_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/antib9030044","article-title":"CD47 as a potential target to therapy for infectious diseases","volume":"9","author":"Cham","year":"2020","journal-title":"Antibodies"},{"issue":"3","key":"10.1016\/j.cellimm.2026.105164_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01293-20","article-title":"Upregulation of CD47 is a host checkpoint response to pathogen recognition","volume":"11","author":"Tal","year":"2020","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02356-1","article-title":"CD47 surface stability is sensitive to actin disruption prior to inclusion within the band 3 macrocomplex","volume":"7","author":"Mordue","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cellimm.2026.105164_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coi.2012.01.010","article-title":"The CD47\u2013SIRP\u03b1 pathway in cancer immune evasion and potential therapeutic implications","volume":"24","author":"Chao","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2026.105164_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350375","article-title":"SIRP\u03b1: a key player in innate immunity","volume":"53","author":"Feng","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2026.105164_bb0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tcb.2008.12.001","article-title":"Functions and molecular mechanisms of the CD47\u2013SIRP\u03b1 signalling pathway","volume":"19","author":"Matozaki","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cellimm.2026.105164_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.887463","article-title":"Role of CD47-SIRP\u03b1 checkpoint in nanomedicine-based anti-Cancer treatment","volume":"10","author":"Liao","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"63","key":"10.1016\/j.cellimm.2026.105164_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001375","article-title":"Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47","volume":"2","author":"Chao","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.cellimm.2026.105164_bb0135","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1073\/pnas.1424907112","article-title":"Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk","volume":"112","author":"Feng","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05211-7","article-title":"Programmed cell removal by calreticulin in tissue homeostasis and cancer","volume":"9","author":"Feng","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cellimm.2026.105164_bb0145","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.chom.2016.01.009","article-title":"Anti-self phosphatidylserine antibodies recognize uninfected erythrocytes promoting malarial Anemia","volume":"19","author":"Fernandez-Arias","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.cellimm.2026.105164_bb0150","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1093\/jimmun\/vkaf151","article-title":"CD47-mediated selective accumulation of mature Ly49h+ NK cells to the brain associates with the pathogenesis of cerebral malaria in mice","volume":"214","author":"Oakley","year":"2025","journal-title":"The Journal of Immunology"},{"issue":"10","key":"10.1016\/j.cellimm.2026.105164_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077615","article-title":"\u2018Clustering\u2019 SIRP\u03b1 into the plasma membrane lipid microdomains is required for activated monocytes and macrophages to mediate effective cell surface interactions with CD47","volume":"8","author":"Ha","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.cellimm.2026.105164_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103024","article-title":"The CIS association of CD47 with integrin mac-1 regulates macrophage responses by stabilizing the extended integrin conformation","volume":"299","author":"Podolnikova","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cellimm.2026.105164_bb0165","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.4049\/jimmunol.167.5.2547","article-title":"Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-\u03b1: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation","volume":"167","author":"Latour","year":"2001","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2026.105164_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13060602","article-title":"Immunotherapeutic blockade of CD47 increases virus neutralization antibodies","volume":"13","author":"Cham","year":"2025","journal-title":"Vaccines"},{"issue":"5473","key":"10.1016\/j.cellimm.2026.105164_bb0175","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cellimm.2026.105164_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70196","article-title":"Immune checkpoint molecules: a review on pathways and immunotherapy implications","volume":"13","author":"Rezazadeh-Gavgani","year":"2025","journal-title":"Immunity, Inflammation and Disease"},{"issue":"3","key":"10.1016\/j.cellimm.2026.105164_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.70030","article-title":"Targeting immune checkpoints: basic signaling pathways and clinical translation in cancer therapeutics","volume":"4","author":"Sun","year":"2025","journal-title":"MedComm \u2013 Oncology"},{"key":"10.1016\/j.cellimm.2026.105164_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878320","article-title":"Increased expression of multiple co-inhibitory molecules on malaria-induced CD8+ T cells are associated with increased function instead of exhaustion","volume":"13","author":"Brandi","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cellimm.2026.105164_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005909","article-title":"Acute malaria induces PD1+CTLA4+ effector T cells with cell-extrinsic suppressor function","volume":"12","author":"Mackroth","year":"2016","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.cellimm.2026.105164_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004589","article-title":"CD47\/SIRP\u03b1 axis: bridging innate and adaptive immunity","volume":"10","author":"van Duijn","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.cellimm.2026.105164_bb0205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ni.2180","article-title":"Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage plasmodium infection","volume":"13","author":"Butler","year":"2011","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2026.105164_bb0210","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.celrep.2013.11.002","article-title":"PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria","volume":"5","author":"Horne-Debets","year":"2013","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/srep26210","article-title":"Mice lacking programmed cell death-1 show a role for CD8+ T cells in long-term immunity against blood-stage malaria","volume":"6","author":"Horne-Debets","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.cellimm.2026.105164_bb0220","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00262-023-03465-9","article-title":"The TSP1-CD47-SIRP\u03b1 interactome: an immune triangle for the checkpoint era","volume":"72","author":"Montero","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2026.105164_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2014.00249","article-title":"Malaria drives T cells to exhaustion","volume":"5","author":"Wykes","year":"2014","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.cellimm.2026.105164_bb0230","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.blre.2018.04.005","article-title":"Blocking \u201cdon't eat me\u201d signal of CD47-SIRP\u03b1 in hematological malignancies, an in-depth review","volume":"32","author":"Russ","year":"2018","journal-title":"Blood Rev."},{"issue":"2","key":"10.1016\/j.cellimm.2026.105164_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189294","article-title":"CD47 as a potent target in cancer immunotherapy: a review","volume":"1880","author":"Ahvati","year":"2025","journal-title":"Biochimica et Biophysica acta (BBA) - reviews on Cancer"},{"issue":"11","key":"10.1016\/j.cellimm.2026.105164_bb0240","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.32604\/or.2025.071708","article-title":"CD47-targeted therapy in Cancer immunotherapy: at a crossroads of promise and challenge","volume":"33","author":"Guo","year":"2025","journal-title":"Oncol. Res."},{"key":"10.1016\/j.cellimm.2026.105164_bb0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jare.2023.10.009","article-title":"Deciphering the role of CD47 in cancer immunotherapy","volume":"63","author":"Liu","year":"2024","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2217\/fon-2022-0975","article-title":"A phase II multi-arm study of magrolimab combinations in patients with relapsed\/refractory multiple myeloma","volume":"19","author":"Paul","year":"2023","journal-title":"Future Oncology (London, England)"},{"issue":"21","key":"10.1016\/j.cellimm.2026.105164_bb0255","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2217\/fon-2018-0035","article-title":"CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises","volume":"14","author":"Tong","year":"2018","journal-title":"Future Oncol."},{"key":"10.1016\/j.cellimm.2026.105164_bb0260","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70763","article-title":"Comparative transcriptomic analysis reveals translationally relevant processes in mouse models of malaria","volume":"11","author":"Georgiadou","year":"2022","journal-title":"ELife"},{"key":"10.1016\/j.cellimm.2026.105164_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00807","article-title":"Humanized mouse models for the study of human malaria parasite biology, pathogenesis, and immunity","volume":"9","author":"Minkah","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0270","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02493-14","article-title":"Malaria induces Anemia through CD8 + T cell-dependent parasite clearance and erythrocyte removal in the spleen","volume":"6","author":"Safeukui","year":"2015","journal-title":"MBio"},{"issue":"16","key":"10.1016\/j.cellimm.2026.105164_bb0275","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1158\/1078-0432.CCR-14-2520","article-title":"Molecular pathways: activating T cells after Cancer cell phagocytosis from blockade of CD47 \u201cDon't eat me\u201d signals","volume":"21","author":"McCracken","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.cellimm.2026.105164_bb0280","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1604268113","article-title":"Durable antitumor responses to CD47 blockade require adaptive immune stimulation","volume":"113","author":"Sockolosky","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Supplement_1","key":"10.1016\/j.cellimm.2026.105164_bb0285","doi-asserted-by":"crossref","first-page":"195.16","DOI":"10.4049\/jimmunol.192.Supp.195.16","article-title":"Intravital imaging shows a key role for splenic DCs in acute malaria for CD4+ T cell activation and parasite clearance (MPF6P.747)","volume":"192","author":"Borges da Silva","year":"2014","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2026.105164_bb0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/jbiol34","article-title":"Suppression of adaptive immunity to heterologous antigens during plasmodium infection through hemozoin-induced failure of dendritic cell function","volume":"5","author":"Millington","year":"2006","journal-title":"J. Biol."},{"issue":"8","key":"10.1016\/j.cellimm.2026.105164_bb0295","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/1535-7163.MCT-17-1095","article-title":"Preclinical development of a bispecific antibody that safely and effectively targets CD19 and CD47 for the treatment of B-cell lymphoma and leukemia","volume":"17","author":"Buatois","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-022-01328-x","article-title":"Targeting macrophages in hematological malignancies: recent advances and future directions","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.cellimm.2026.105164_bb0305","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ejca.2014.03.004","article-title":"Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma","volume":"50","author":"Goto","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.cellimm.2026.105164_bb0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/19768354.2020.1818618","article-title":"CD47 (cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions","volume":"24","author":"Leclair","year":"2020","journal-title":"Animal Cells and Systems"},{"issue":"7","key":"10.1016\/j.cellimm.2026.105164_bb0315","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI81603","article-title":"CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer","volume":"126","author":"Weiskopf","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0320","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2111909","article-title":"Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice","volume":"11","author":"Nath","year":"2022","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0325","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1038\/s41598-019-42366-9","article-title":"PfMSA180 is a novel plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47)","volume":"9","author":"Nagaoka","year":"2019","journal-title":"Sci. Rep."},{"issue":"98","key":"10.1016\/j.cellimm.2026.105164_bb0330","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adk9872","article-title":"The human CD47 checkpoint is targeted by an immunosuppressive Aedes aegypti salivary factor to enhance arboviral skin infectivity","volume":"9","author":"Marin-Lopez","year":"2024","journal-title":"Sci. Immunol."},{"issue":"8","key":"10.1016\/j.cellimm.2026.105164_bb0335","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/jac\/dks132","article-title":"Curcumin enhances non-opsonic phagocytosis of plasmodium falciparum through up-regulation of CD36 surface expression on monocytes\/macrophages","volume":"67","author":"Mimche","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"9315","key":"10.1016\/j.cellimm.2026.105164_bb0340","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(02)08360-5","article-title":"Mechanism of protection induced by vitamin a in falciparum malaria","volume":"359","author":"Serghides","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.cellimm.2026.105164_bb0345","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/598222","article-title":"Rosiglitazone modulates the innate immune response to plasmodium falciparum infection and improves outcome in experimental cerebral malaria","volume":"199","author":"Serghides","year":"2009","journal-title":"J Infect Dis"},{"issue":"33","key":"10.1016\/j.cellimm.2026.105164_bb0350","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.1074\/jbc.M116.770313","article-title":"Small molecule\u2013based inhibition of MEK1\/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes","volume":"292","author":"Wu","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0355","doi-asserted-by":"crossref","first-page":"12998","DOI":"10.1038\/s41598-018-31171-5","article-title":"Rab GTPase regulation of bacteria and protozoa phagocytosis occurs through the modulation of phagocytic receptor surface expression","volume":"8","author":"Seixas","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cellimm.2026.105164_bb0360","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4049\/jimmunol.2100352","article-title":"CD47 blockade leads to chemokine-dependent monocyte infiltration and loss of B cells from the splenic marginal zone","volume":"208","author":"Yiu","year":"2022","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.cellimm.2026.105164_bb0365","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12830","article-title":"Innate immunity to malaria\u2014the role of monocytes","volume":"293","author":"Dobbs","year":"2020","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.cellimm.2026.105164_bb0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-015-0476-6","article-title":"Pathogenic CD8+ T cells in experimental cerebral malaria","volume":"37","author":"Howland","year":"2015","journal-title":"Semin. Immunopathol."},{"issue":"22","key":"10.1016\/j.cellimm.2026.105164_bb0375","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1074\/jbc.M117.781294","article-title":"CD36 receptor regulates malaria-induced immune responses primarily at early blood stage infection contributing to parasitemia control and resistance to mortality","volume":"292","author":"Thylur","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"7833","key":"10.1016\/j.cellimm.2026.105164_bb0380","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-020-2530-3","article-title":"Structural basis for RIFIN-mediated activation of LILRB1 in malaria","volume":"587","author":"Harrison","year":"2020","journal-title":"Nature"},{"issue":"7683","key":"10.1016\/j.cellimm.2026.105164_bb0385","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature24994","article-title":"Immune evasion of plasmodium falciparum by RIFIN via inhibitory receptors","volume":"552","author":"Saito","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2026.105164_bb0390","series-title":"Potent LILRB1 D1D2-containing antibodies inhibit RIFIN-mediated immune evasions","author":"Wang","year":"2024"},{"issue":"4","key":"10.1016\/j.cellimm.2026.105164_bb0395","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlag016","article-title":"Cellular and molecular interactions underlying the peripheral immune responses to blood-stage malaria infections","volume":"10","author":"Tebben","year":"2026","journal-title":"ImmunoHorizons"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492600105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492600105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:49:56Z","timestamp":1792115396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887492600105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":79,"alternative-id":["S000887492600105X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2026.105164","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking CD47 an innate immune checkpoint and immunotherapeutic target in malaria pathogenesis: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2026.105164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105164"}}